Combination of drug-eluting bead transarterial chemoembolization and PD-1 inhibitor for treatment of unresectable head and neck squamous cell carcinoma: an initial, short-term clinical experience in a single-center retrospective cohort study

Combination of drug-eluting bead transarterial chemoembolization and PD-1 inhibitor for treatment of unresectable head and neck squamous cell carcinoma: an initial, short-term clinical experience in a single-center retrospective cohort study

IntroductionThis study investigated the clinical efficacy and safety of CalliSpheres® drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with programmed death protein (PD)-1 inhibitors for treatment of unresectable head and neck squamous cell carcinoma (HNSCC).MethodsClinical data...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo Sun, Jin Qi Gao, Ruo Jie Li, Lei Song, Na Li, Fei Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
camrelizumab
drug-eluting CalliSpheres® -beads
head and neck malignancies
squamous cell carcinoma
transarterial chemoembolization
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1615440/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1615440/full

Similar Items